Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
SCHA, the Schwab U.S. Small-Cap ETF, is a fund where very little about the short side normally warrants attention. That changed in September. Short interest has more than doubled in a month, the put/call ratio is running above its recent average, and the fund is down 4.2% in October.
The short interest story is the standout here, not because the absolute level is threatening but because the rate of change is striking. Shares short climbed to around 2.64 million, equivalent to 0.39% of the float, on October 6. That is still a low absolute level for an ETF of this size, but the one-month increase of roughly 103% is worth noting. The build has been fairly steady since mid-September, when shares short were closer to 760,000. At the same time, the borrow market remains loose. Availability is at 265%, meaning there are more than 2.6 shares available to lend for every one already borrowed. Cost to borrow is just 0.44%, up sharply on the week in percentage terms but still well within normal territory for an ETF. The lending dynamics do not suggest squeeze pressure; they suggest incremental positioning rather than a crowded short.
Options positioning has shifted toward mildly more defensive ground. The put/call ratio is at 0.076, about 1.5 standard deviations above its 20-day average of 0.062. That is not an extreme reading. The 52-week high for the PCR is 0.196, and the current level is far below that. But the direction matters: through most of August and early September, the PCR was hugging 0.05 to 0.056. The recent lift toward 0.075 to 0.076 reflects a modest rotation toward downside hedging. Taken alongside the short build, investors appear to be paying more attention to tail risk in small-caps than they were six weeks ago.
The ORTEX short score has drifted up to 39.2, a fresh recent high though still in the middle of the 0-100 range. The score has been climbing since late September, when it sat below 32. That trajectory is consistent with the rest of the positioning picture: incremental caution building, not alarm.
For context, the fund closed at $33.10 on October 6, down 4.2% over the past month and off 0.4% on the day, though it did recover 1% on the week. The most recent dividend print in September was $0.1005, broadly in line with the prior quarterly payment, so there is no income story distorting the price picture. Valuation multiples at the ETF level are not meaningful, and no analyst coverage applies here.
What to watch is whether the short build continues to accelerate or plateaus: if shares short push materially above the current 2.6 million level while availability begins to tighten from the current loose 265%, that would mark a more substantive shift in how the market is leaning on U.S. small-caps.
See the live data behind this article on ORTEX.
Open SCHA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
